Showing results (2291-2300 of 4,400) with videos related to
Sort By:
Pageof 440
Toxins|November 17, 2015
Delay of the onset of puberty in female rats by prepubertal exposure to T-2 toxinRong Yang, Yi-Mei Wang, Li-Shi Zhang, et al.BMC Urology|October 14, 2021
Cavernous lymphangioma of the urinary bladder in an adult woman: an additional case report of a rare lesion and literature reviewWei He, Li Jin, Fang-Fang Lin, et al.Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|September 12, 2018
Risk Factors for Lower Limb Deep Vein Thrombosis in Patients With Single-Level Lumbar Fusion: A Prospective Study of 710 CasesChun-Ming Zhao, Yu Zhang, Si-Dong Yang, et al.Acta Biochimica Et Biophysica Sinica|January 9, 2009
Inactivation of LARS2, located at the commonly deleted region 3p21.3, by both epigenetic and genetic mechanisms in nasopharyngeal carcinomaWen Zhou, Xiangling Feng, Hong Li, et al.Bioorganic & Medicinal Chemistry|February 23, 2010
Benzyl 1,2,3,5,11,11a-hexahydro-3,3-dimethyl-1-oxo-6H-imidazo[3',4':1,2]pyridin[3,4-b]indole-2-substituted acetates: One-pot-preparation, anti-tumor activity, docking toward DNA and 3D QSAR analysisJiawang Liu, Ming Zhao, Keduo Qian, et al.Drug Design, Development and Therapy|September 14, 2016
Nanomedical strategy to prolong survival period, heighten cure rate, and lower systemic toxicity of S180 mice treated with MTX/MITNing Song, Ming Zhao, Yuji Wang, et al.Molecular Medicine Reports|August 31, 2016
Curcumin inhibits osteoclastogenic potential in PBMCs from rheumatoid arthritis patients via the suppression of MAPK/RANK/c-Fos/NFATc1 signaling pathwaysWei Shang, Ling-Jie Zhao, Xiao-Lei Dong, et al.International Journal of Nanomedicine|May 12, 2017
Quantitative and multiplexed detection for blood typing based on quantum dot-magnetic bead assayTing Xu, Qiang Zhang, Ya-Han Fan, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 26, 2010
FcgammaRIIB inhibits the development of atherosclerosis in low-density lipoprotein receptor-deficient miceMing Zhao, Maria Wigren, Pontus Dunér, et al.Clinical Lung Cancer|May 4, 2017
Local Therapy for Oligoprogressive Disease in Patients With Advanced Stage Non-small-cell Lung Cancer Harboring Epidermal Growth Factor Receptor MutationBo Qiu, Ying Liang, QiWen Li, et al.Pageof 440